Prescription medication abuse accounts for a significant percentage of drug use in the United States.1  Nonmedical use of prescription medications is now the second most prevalent category of illicit drug abuse after marijuana in U.S. among adolescents and young adults, and in 2012, it was the leading cause of injury death for those age 25-64, surpassing deaths due to car accidents.2,3 With opioid painkillers representing a key element of pain management, urine drug testing has become more essential as healthcare providers ensure their patients are adhering to their treatment plans. Routine urine drug testing also allows for the detection of illicit or unauthorized drugs that may not have been disclosed by the patient.4 Developing strong testing guidelines in your practice can help prevent prescription drug abuse, misuse, and diversion. Kashi Toxicology provides prescription pain medication monitoring services to physicians that includes rapid 1-2 days turnaround from time of specimen delivery.

Gene Tests
Antidepressants (SNRIs) [coming soon] Duloxetine, Venlafaxine CYP2D6
Antidepressants (TCAs) [coming soon] Amitriptyline, Clomipramine, Doxepin, Imipramine CYP2C19, CYP2D6
Muscle Relaxants Carisoprodol CYP2C19
NSAIDs Celecoxib, Flurbiprofen CYP2C9
Opioids Tramadol, Codeine, Oxycodone, Morphine COMT4

Read Scientific References